Retinal Disease: New Horizons In the Bio-chemistry Of Vision – Dr. Stephen Redenti
Dr. Stephen Redenti, Professor of Biochemistry and Molecular Biology at The City University of New York, provides an overview of critical signaling processes that can shed light on retinal health and the origins of degenerative retinal disease. Dr. Redenti explores how decades of research into the biochemistry of tumor metastasis is now informing novel therapeutic approaches that aim to improve the success of stem cell therapies for Retinitis Pigmentosa and other ophthalmic diseases.
About the guest:
Stephen Redenti Ph.D. is a Professor at the City University of New York, Lehman College and Graduate Center Biochemistry, Molecular, Cell and Developmental Biology and Neuroscience doctoral programs. His lab’s research focuses on retinal extracellular vesicle molecular cargo and function, migration of transplantable photoreceptor replacement cells, and natural compounds for treatment of ocular and neuroblastoma cancers.
Dr. Redenti has a successful training record with STEM students from the Bronx High School of Science, City University of New York undergraduate, masters and doctoral programs. He coordinates teaching technique training for postdoctoral scientists from the Albert Einstein College of Medicine IRACDA program. He is also Board Member for the African American Planning Commission, a housing, social service and community development organization.
Leave a Reply